4.0
Jul 17, 2015
Anonymous employee
Former employee, more than 10 years
Ginebra
Recommend
CEO approval
Business Outlook
Pros
very 'mature' organisation with good management culture and 'matrix' approach to projects
Cons
more risk adverse than I would like - drug development is in my view more risky than they would like , alongside their lower risk/ more predictable chemicals & lab businesses